|
|
|
Published online before print
June 12, 2001, 10.1101/gr.GR-1578R
Vol. 11, Issue 7, 1262-1268, July 2001
METHODS
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
To make large-scale association studies a reality, automated
high-throughput methods for genotyping with single-nucleotide polymorphisms (SNPs) are needed. We describe PCR conditions that permit
the use of the TaqMan or 5' nuclease allelic discrimination assay for
typing large numbers of individuals with any SNP and computational
methods that allow genotypes to be assigned automatically. To
demonstrate the utility of these methods, we typed >1600 individuals for a G-to-T transversion that results in a glutamate-to-aspartate substitution at position 298 in the endothelial nitric oxide synthase gene, and a G/C polymorphism (newly identified in our laboratory) in
intron 8 of the 11-
hydroxylase gene. The genotyping method is
accurate
we estimate an error rate of fewer than 1 in 2000 genotypes,
rapid
with five 96-well PCR machines, one fluorescent reader, and no
automated pipetting, over one thousand genotypes can be generated by
one person in one day, and flexible
a new SNP can be tested for
association in less than one week. Indeed, large-scale genotyping has
been accomplished for 23 other SNPs in 13 different genes using this
method. In addition, we identified three "pseudo-SNPs" (WIAF1161,
WIAF2566, and WIAF335) that are probably a result of duplication.
| |
INTRODUCTION |
|---|
|
|
|---|
Single-nucleotide polymorphisms, or SNPs, have become
prominent in human genetics, and their popularity can be attributed to
several reasons. The failure of linkage analysis to identify, in a
convincing way, loci for complex diseases has led to interest in
large-scale association studies for mapping genes for complex traits
(Risch and Merikangas 1996
; Collins et al. 1997
). Because SNPs are the
most abundant, accessible class of polymorphisms present in the human
genome, the use of as many as one million SNPs scattered across the
human genome was envisioned for such studies. Substantial effort is
being devoted by the SNP Consortium toward developing a more modest SNP
map comprising 300,000 markers (Masood 1999
). The second reason for the
current popularity of SNPs is the potential ease with which they can be
used for genotyping. In contrast to the tri- and tetranucleotide
markers used in linkage analysis, SNPs, because they are usually
biallelic, are more amenable to automated detection. This difference could
result in considerable savings in the cost and time required for genotyping.
Our group, the Stanford, Asia, Pacific Program for Hypertension and
Insulin Resistance (SAPPHIRe), is devoted to identifying susceptibility
genes for essential hypertension, a complex trait, in populations of
Chinese and Japanese origin. To this end, we have begun a systematic
survey of candidate genes that might be involved in regulating blood
pressure. Our approach is to identify SNPs in such genes and test these
for association in a large population comprised of subjects that have
very high or low-normal blood pressure. The general validity of
association results needs to be determined by testing the same
polymorphism in different populations. The Family Blood Pressure
Program (FBPP) of the National Heart, Lung, and Blood Institute, of
which SAPPHIRe is a member, was established with this objective in
mind. Because members of the FBPP have recruited subjects of diverse
origins
from Asian samples like ours, as well as from Caucasian,
Hispanic, and African-American populations from the United States
a
positive association result in one population can be quickly tested in
another. Thus, the FBPP in general, and SAPPHIRe in particular, needed
methods to rapidly test different SNPs in a large number of subjects
(>4000). We therefore focused on developing tools that will facilitate high-throughput genotyping using SNPs.
Here we have examined the suitability of the 5' nuclease allelic
discrimination or TaqMan assay (Livak et al. 1995
) for high-throughput genotyping. In this method, the region flanking the polymorphism, typically 100 base pairs, is amplified in the presence of two probes
each specific for one or the other allele. Probes have a fluor, called
"reporter," at the 5' end but do not fluoresce when free in
solution because they have a "quencher" at the 3' end that absorbs
fluorescence from the reporter. During PCR, the Taq polymerase
encounters a probe specifically base-paired with its target and unwinds
it. The polymerase cleaves the partially unwound probe and liberates
the reporter fluor from the quencher, thereby increasing net
fluorescence. The presence of two probes, each labeled with a different
fluor, allows one to detect both alleles in a single tube. Moreover,
because probes are included in the PCR, genotypes are determined
without any post-PCR processing, a feature that is unavailable with
most other genotyping methods (for a recent review, see Landegren et
al. 1998
).
We describe PCR conditions that facilitate accurate and rapid
genotyping of large numbers of individuals with large numbers of SNPs
and computational methods that permit one to automate the
allele-calling procedure
a key requisite for any high-throughput genotyping method. To demonstrate the utility of these methods, we
typed >1600 subjects for a SNP in the endothelial nitric oxide synthase gene and another in the 11-
-hydroxylase gene. In addition, we uncovered three "pseudo-SNPs" that appear to be the result of
adjacent duplications.
| |
RESULTS |
|---|
|
|
|---|
High-Throughput Genotyping with the TaqMan Assay
We used the TaqMan assay to type 1699 individuals for two unrelated
SNP markers on different chromosomes: One is a G/T transversion that
results in a glutamate-to-aspartate substitution at position 298 in the
endothelial nitric oxide synthase gene (eNOSE298D; Miyamoto
et al. 1998
), and the other is a C/G transversion in intron 8 (newly
identified in our laboratory) of the 11-
hydroxylase gene
(CYP11B15). DNA samples and a mixture containing buffer, probes, primers, and polymerase were distributed in 96-well plates and
fluorescence in each was measured prior to PCR. Following PCR in a
standard 96-well machine, fluorescence was measured again for each
sample. Post-PCR data from all the plates were imported into a
statistical software package and fluorescence from the two reporters
was plotted.
As shown in Figure 1A, for the
eNOSE298D SNP, there were no obvious outliers, but samples
from one PCR plate formed a separate group. Comparison of mean pre-PCR
fluorescence values for both dyes from this plate with those from other
plates revealed that there was significantly less fluorescence from the
reporter dyes in all wells of this plate. Because the magnitude of
post-PCR fluorescence was proportional to that prior to PCR, we
adjusted post-PCR fluorescence for this plate accordingly.
k-means clustering was then used to automatically classify
samples into four groups
the three genotypes and a "no DNA"
control group (Fig. 1B).
|
The particular k-means clustering algorithm used for assigning
genotypes in this study is based on nearest-centroid sorting (Anderberg
1973
; Sharma 1996
). In this method, data are classified into a
predetermined number of groups or clusters; a case is assigned to the
cluster with the smallest distance between the case and the center of
the cluster (centroid). Cluster centers are not known in advance but
are iteratively estimated from the data. As can be seen (Fig. 1B), the
classification is good with no overlap between different genotype
clusters. A small number of samples (15) failed to amplify, and the
algorithm correctly placed these in the no DNA control group.
The results for the CYP11B15 SNP are shown in Figure 2. As can be seen from the raw data (Fig. 2A), there were no outliers and, unlike in the eNOSE298D case, all the plates yielded similar post-PCR fluorescence values. The output of the k-means clustering is plotted in Figure 2B. For this particular SNP, only four samples failed to amplify robustly and these were classified appropriately in the no DNA control group. For both SNPs, assay failure was probably due to pipetting error because these samples gave robust genotypes for other SNPs.
|
Over twenty different SNPs (Table 1) have
been used for large-scale genotyping using this method and yield
results that are similar to those presented here (see www.genome.org
for these data).
|
To monitor the quality of genotyping and allele-calling procedure, >200 samples, of which 56 were blind, were typed in duplicate for both SNPs; there were no discordancies. Based on similar genotyping data for SNPs listed in Table 1, we estimate the error-rate to be <1 in 2000 genotypes. Further, for the CYP11B15 SNP, for 17 samples we compared TaqMan genotypes to those obtained by direct sequencing. This set of samples included nine C/C homozygotes, seven C/G heterozygotes, and one G/G homozygote; again, there were no discrepancies.
Detection of Pseudo-SNPs
In the course of developing TaqMan assays for a genome-wide map of
SNPs, we encountered three SNPs (WIAF1161, WIAF2566, and WIAF335)
that were apparently not polymorphic
30 unrelated individuals tested
were heterozygous (see Fig. 3, Genomic
DNA). A trivial possibility is that the probes used in the TaqMan assay
failed to distinguish between the two alleles. As can be seen in Figure 3 (Synthetic templates), this is not the case. Synthetic templates carrying one or the other allele were constructed by annealing the
appropriate oligonucleotides and "filling in" the resulting partial
duplexes. For all three SNPs, the two synthetic alleles can be
distinguished from each other by the same probes and primers used to
type genomic DNA. Furthermore, artificial heterozygotes made by mixing
the two synthetic alleles can be easily distinguished from the two
homozygotes.
|
We hypothesized, therefore, that duplications that differ from one
another at a single nucleotide, and thus render all individuals heterozygous, had been misinterpreted as SNPs. If this were true, and
the duplications were scattered across the genome, then the two alleles
would be expected to segregate among cell lines used in
radiation-hybrid mapping. If, on the other hand, the duplications were
in close proximity, then they would be expected to "cosegregate" in
the low-resolution mapping panel used here. The results presented in
Table 2 show that this latter hypothesis
appears to be correct. We typed the Genebridge 4 radiation-hybrid
mapping panel for the presence or absence of these three pseudo-SNPs
and for three others that were polymorphic. For all three pseudo-SNPs,
all cell-lines tested harbor both copies of the duplication or neither.
In contrast, for markers WIAF2065, 2042, 896, and 610 that are indeed
polymorphic, the two alleles "segregate" among the radiation-hybrid
cell lines
cell lines carry one or the other allele. In the cases of
WIAF896, 610, and 2065 a handful of cell lines are "heterozygous"
and bear both alleles.
|
| |
DISCUSSION |
|---|
|
|
|---|
High-Throughput Genotyping with SNPs
For large-scale association studies to become a reality,
high-throughput genotyping methods that are accurate and flexible and
use uniform conditions for typing different SNPs will be required. Several methods are currently available that offer the promise of
accurate high-throughput genotyping. These include the TaqMan assay
(Livak et al. 1995
), oligonucleotide-ligation assays or OLAs (Tobe et
al. 1996
), minisequencing (Chen and Kwok 1997
; Pastinen et al. 1997
),
molecular beacons (Tyagi et al. 1998
), dye-labeled oligonucleotide
ligation (Chen et al. 1998
), chips (Hacia et al. 1998
; Wang et al.
1998
), mass spectrometry (Ross et al. 1998
), and the invader assay
(Mein et al. 2000
). These methods, as presently employed, rely on a PCR
step to increase the concentration of a segment of DNA sequence
carrying the SNP; they diverge in their method of detecting alleles
following this amplification step.
TaqMan and molecular beacons, because they incorporate allele-specific
probes in the PCR, combine the amplification and detection steps and
require no post-PCR processing for determining genotypes
for each
reaction, fluorescence is merely measured after PCR and genotypes are
inferred based on these values. The other methods, in contrast, require
significant post-PCR processing. For instance, in the chip-based method
used by Wang et al. (1998)
, amplified products are purified to remove
nucleotides, enzymes, primers, etc. These purified samples are then
hybridized for 15 h to oligonucleotides arrayed on chips; after several
additional washing and developing steps, genotypes are determined. In
some assays, such as the invader, after amplification, separate
reactions are performed to distinguish the two alleles (Mein et al.
2000
). These separate reactions could potentially lead to errors
because if one reaction fails and the other succeeds, then a
heterozygote could be misinterpreted as a homozygote. Although such
artifacts can be controlled and many of the post-PCR steps automated,
we believe that methods that do not require processing of amplified
products are more suited to accurate and high-throughput genotyping. We
have, therefore, focused our efforts on one such method
the 5'
nuclease allelic discrimination assay or TaqMan. Here we describe tools
that make the method accurate, rapid, and flexible, and each of these
points is considered below.
We estimate the error-rate to be <1 in 2000 genotypes. Two factors
contributed to achieving this high level of accuracy: uniform buffer
conditions and automated assignment of genotypes. We ensured uniform
buffer conditions by using a single large batch of master-mix (i.e.,
buffer, nucleotides, polymerase, probes, and primers mixture) for
typing all of the samples for a given SNP. We have found that small
differences in buffer conditions, such as might result from errors
pipetting into individual wells or plates, cause variation in post-PCR
fluorescence values. It turned out to be the general case that applying
the correction factor derived from the relative pre-PCR fluorescence of
the several plates being compared (exemplified in Fig. 1A,B) deals well
with this problem. Thereafter, we could pool data across different
plates and thereby fully automate the procedure for assigning
genotypes. Genotypes are assigned automatically using k-means
clustering. This method of allele-calling eliminates human bias and
allows one to assign a "quality score" to each genotype. This score
is the probability that a particular sample falls within a genotype
class given its fluorescence values for each reporter dye. If
fluorescence values within a cluster are approximately normally
distributed, then calculating this probability is straightforward
it
is simply the probability of observing a certain value given a
bivariate normal density (see Methods). As shown in Figures 1B and 2B,
a few samples (three and two, respectively) have a low probability of
belonging to the assigned cluster using this criterion. To our
knowledge, this is the first time that k-means clustering
coupled with a quality score has been used in assigning genotypes at SNPs.
The particular k-means clustering algorithm implemented here is not foolproof. Egregious outliers with very high or very low fluorescence values, which can result, for example, from contaminants in the DNA, defeat the clustering algorithm and result in classification that is obviously wrong. We note, however, that cursory visual examination of a plot of the data can usually identify these outliers.
The conditions for PCR used here
900 nM each primer, 250 nM each
probe, and an annealing/extension temperature of 62°C
are, with
minor modifications, generally applicable. One parameter, the
annealing/extension temperature needs to be optimized for each new SNP.
We generally test two temperatures, 62°C and 64°C, for a new SNP.
With improvements in programs that calculate melting temperatures, we
expect that even this step can be eliminated. Over 20 different SNPs
(Table 1) have been used for large-scale genotyping under these
conditions, and yield results that are similar to those presented here.
These uniform conditions make the assay flexible and enable one to
accommodate a new SNP easily. With five 96-well PCR machines, one
fluorescent reader and no automated pipetting, >1000 genotypes can be
generated by one person in one day. Thus, in our hands, once a new SNP
is identified, a large-scale association study with 2000 samples can be
performed in less than a week. With more PCR machines and automated
pipetting stations, we expect that the throughput could be increased by at least an order of magnitude.
The genotyping routine described here is suitable for typing large numbers of individuals for selected SNPs in tens or even hundreds of candidate genes. However, there are two impediments to the use of TaqMan, as implemented here, for whole-genome association studies: the amount of DNA used in the PCR and the cost per genotype. If 30 ng of DNA are used for typing each SNP, then a genome scan with 300,000 SNPs will require a minimum of 9 mg of DNA, an amount far in excess of that available from typical blood samples obtained at clinics. We estimate that the cost of reagents per TaqMan genotype is ~$1.50; at this price, a whole-genome scan for 2000 individuals with 300,000 SNPs will cost almost one billion US dollars. Clearly, the amount of DNA and the cost per genotype will need to be reduced significantly for whole-genome association studies to become practical.
For the TaqMan method we can envision at least two improvements. First,
the PCR can be miniaturized, perhaps to nanoliter volumes (25µL
reactions were used in this study), thereby decreasing the cost of
reagents and conserving precious DNA samples. A thousand-fold reduction
in volume would bring the assay into a scale that might be both
feasible and affordable. Second, with improvements in TaqMan chemistry
(e.g., probes with higher specificity) it should be possible to
genotype pools of DNA, as opposed to individual samples as was done
here, thus further conserving reagents and effort. An alternative
method to determining allele frequencies in pools of DNA is to run the
TaqMan assay in real time (Germer et al. 2000
). However, for
high-throughput genotyping, this approach would require a large number
of expensive fluorescent readers. A limitation of the pooling method is
that individual genotypes would not be provided, thus complicating
analyses of haplotypes.
To conclude, we believe that the TaqMan assay is technically adequate for fully automated genotyping of SNPs on a scale required for genome-wide association studies, provided only that further miniaturization to a nanoliter scale is carried out. We have used the current implementation to genotype ~1700 individuals for tens of markers and have found the method to be robust in daily use. To our knowledge, this is the first time that a method for typing SNPs has been assessed on such a large scale. Furthermore, the automated allele-calling procedure we have implemented should be generally applicable to any fluorescence-based genotyping method.
| |
METHODS |
|---|
|
|
|---|
Genotyping
The PrimerExpress program (Perkin-Elmer, Applied Biosystems
Division) was used to design probes and primers. For the eNOSE289D SNP
the approximate melting temperatures of probes and primers were 67°C
and 61°C, respectively. For the CYP11B15 SNP, probes and
primers were calculated to have melting temperatures of ~70°C and
62°C, respectively. The sequences of the primers and probes used in
this study are given in Table 3. Each 25 µL PCR contained 30 ng of genomic DNA, 900 nM primers, 250 nM probes,
and 12.5 µL of TaqMan Universal PCR master mix (Perkin-Elmer, Applied
Biosystems Division), which is a solution containing buffer,
Uracil-N-glycosylase, deoxyribonucleotides, uridine, passive reference
dye (ROX), and TaqGold DNA polymerase. We found that, for authentic
SNPs, over 90% of the TaqMan assays we tested under these conditions
give usable genotypes without further optimization of the assay. We have also found that as little as 100 nM probes can be used in the PCR
reaction, with results that are comparable to those presented here. For
consistently poolable results (see below), it was found necessary to
type all subjects for a given SNP with a single lot of PCR master mix.
Amplification was done under the following conditions: 50°C, 2 min;
95°C, 10 min; followed by 40 cycles of 94°C, 15 sec and 62°C, 1 min in a Perkin-Elmer 9600 thermocycler. Fluorescence in each well was
measured before and after PCR using a ABI 7700 machine (Perkin Elmer,
Applied Biosystems Division). Patient population has been described
previously (Ranade et al. 2000
).
|
Statistical Analyses
Normalized fluorescence values (Rn), defined as the amount of fluorescence from each reporter dye divided by that from the reference dye, were imported into a statistical software package (SPSS version 6.1). To correct for pipetting errors, fluorescence values were measured prior to the PCR. In principle, prior to PCR all wells of all of the plates should have equal amounts of fluorescence from either reporter or reference dyes. In practice, however, because of variation in pipetting, these amounts tend to vary and eventually cause predictable variation in post-PCR fluorescence values. To account for these pre-PCR differences, mean fluorescence values prior to PCR for each reporter dye were calculated for each plate. If the mean value of a particular plate is significantly different from the others, as judged by a non-parametric Wilcoxon signed-ranks test, then post-PCR values for that particular plate are adjusted accordingly. For this study, only one plate of samples needed to be adjusted for the eNOSE298D SNP (see Fig. 1).
k-means clustering was used to classify data into four groups.
In this method of partitioning the data, cases are assigned to a
predetermined number of groups. In this case, the number of groups is
the number of genotype classes
three
and a no DNA control group.
Squared Euclidean distances were used in the clustering, and cluster
centers were estimated iteratively from the data. Fifty iterations were
permitted, but clustering was terminated after only four iterations
because there was no change in cluster centers.
If one assumes that the distribution of fluorescence values within a
cluster is approximately bivariate normal, then the conditional probability (Pi(x)) that a sample with particular Rn
values (x) falls within a particular cluster or genotype class is given by the formula:
|
Radiation Hybrid Analysis
The Genebridge 4 panel (Research Genetics) was used to analyze pseudo-SNPs. The primers and probes used to detect each SNP are listed in Table 3. PCR conditions were as described above, except that 25 ng of DNA from each radiation-hybrid cell line was used and PCR was done using an ABI 7700 machine. Following PCR, fluorescence values were read on the same machine and each cell line was scored for the presence or absence of signal from either reporter.
For SNPs WIAF1161, WIAF2566, and WIAF335, synthetic templates bearing
one or the other allele were constructed as follows. The "top"
oligonucleotide (~40 nucleotides) was annealed to two "bottom"
oligonucleotides (~70 nucleotides), which differed from each other at
the single polymorphic nucleotide. Annealing was carried out in a 100 µL volume containing 2 µM of each oligonucleotide, 10 mM Tris at pH
7.5, 6 mM MgCl2, 50 mM NaCl, and 5.76 mM
-mercaptoethanol. After denaturing the oligonucleotides at 95°C for 1 min, the solution was slowly cooled to room temperature. Five units of Klenow polymerase were added and the reaction was incubated at room temperature for 20 min. The reaction was stopped by adding EDTA to a final concentration
10 mM and heating to 70°C for 20 min. One or two µL of a
10
3 or 2 × 10
3 dilution of this solution was
used in the TaqMan PCR.
| |
ACKNOWLEDGMENTS |
|---|
We thank subjects for participating in this study. Ken Livak and Mike Lucero of Perkin-Elmer, Applied Biosytems Division, helped greatly with the TaqMan assays. This paper is written on behalf of members of the Stanford, Asia, and Pacific program for Hypertension and Insulin resistance (SAPPHIRe). We thank Susan Old, Steve Mockrin, and Cashell Jaquish of the National Heart, Lung, and Blood Instittute (NHLBI) for helpful discussions. This work is funded by a grant from the Family Blood Pressure Program of the NHLBI, National Institutes of Health.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
FOOTNOTES |
|---|
10 Present address: Pharmaceutical Research Institute, Bristol-Myers Squibb, Applied Genomics, Princeton, NJ 08543-5400.
11 Corresponding authors.
12 E-MAIL koustubh.ranade{at}bms.com; FAX (609) 818-5839.
13 E-MAIL botstein{at}genome.stanford.edu; FAX (650) 723-7016.
Article published on-line before print: Genome Res., 10.1101/gr. 157801.
Article and publication are at http://www.genome.org/cgi/doi/10.1101/gr.157801.
| |
REFERENCES |
|---|
|
|
|---|
2-adrenergic receptor regulate receptor expression.
J. Clin Invest.
102:
1927-1932.
3-adrenergic-receptor gene.
N. Engl. J. Med.
333:
343-347.Received August 2, 2000; accepted in revised form April 2, 2001.
This article has been cited by other articles:
![]() |
H. J. Ryynanen, A. Tonteri, A. Vasemagi, and C. R. Primmer A Comparison of Biallelic Markers and Microsatellites for the Estimation of Population and Conservation Genetic Parameters in Atlantic Salmon (Salmo salar) J. Hered., November 5, 2007; (2007) esm093v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Rame, M. H. Drazner, W. Post, R. Peshock, J. Lima, R. S. Cooper, and D. L. Dries Corin I555(P568) Allele Is Associated With Enhanced Cardiac Hypertrophic Response to Increased Systemic Afterload Hypertension, April 1, 2007; 49(4): 857 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takitoh, S. Fujii, Y. Mase, J. Takasaki, T. Yamazaki, Y. Ohnishi, M. Yanagisawa, Y. Nakamura, and N. Kamatani Accurate automated clustering of two-dimensional data for single-nucleotide polymorphism genotyping by a combination of clustering methods: evaluation by large-scale real data Bioinformatics, February 15, 2007; 23(4): 408 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tanaka, A. J. Sandford, K. Burkett, J. E. Connett, N. R. Anthonisen, P. D. Pare, and J-Q. He Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers Eur. Respir. J., January 1, 2007; 29(1): 34 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Aquilante, I. Zineh, A. L. Beitelshees, and T. Y. Langaee Common laboratory methods in pharmacogenomics studies. Am. J. Health Syst. Pharm., November 1, 2006; 63(21): 2101 - 2110. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Szantai, Z. Ronai, M. Sasvari-Szekely, G. Bonn, and A. Guttman Multicapillary Electrophoresis Analysis of Single-Nucleotide Sequence Variations in the Deoxycytidine Kinase Gene Clin. Chem., September 1, 2006; 52(9): 1756 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Warrington, A R Vieira, K Christensen, I M Orioli, E E Castilla, P A Romitti, and J C Murray Genetic evidence for the role of loci at 19q13 in cleft lip and palate. J. Med. Genet., June 1, 2006; 43(6): e26 - e26. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Daimon, G. Ji, T. Oizumi, T. Kido, M. Baba, Y. Jimbu, W. Kameda, S. Susa, H. Yamaguchi, H. Ohnuma, et al. Association of Nephrin Gene Polymorphisms With Type 2 Diabetes in a Japanese Population: The Funagata Study Diabetes Care, May 1, 2006; 29(5): 1117 - 1119. [Full Text] [PDF] |
||||
![]() |
M. Iemitsu, S. Maeda, T. Otsuki, J. Sugawara, T. Tanabe, S. Jesmin, S. Kuno, R. Ajisaka, T. Miyauchi, and M. Matsuda Polymorphism in Endothelin-Related Genes Limits Exercise-Induced Decreases in Arterial Stiffness in Older Subjects Hypertension, May 1, 2006; 47(5): 928 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sotoodehnia, D. S. Siscovick, M. Vatta, B. M. Psaty, R. P. Tracy, J. A. Towbin, R. N. Lemaitre, T. D. Rea, J. P. Durda, J. M. Chang, et al. {beta}2-Adrenergic Receptor Genetic Variants and Risk of Sudden Cardiac Death Circulation, April 18, 2006; 113(15): 1842 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Anderson and J. C. Garza The Power of Single-Nucleotide Polymorphisms for Large-Scale Parentage Inference Genetics, April 1, 2006; 172(4): 2567 - 2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Callegaro, R. Spinelli, L. Beltrame, S. Bicciato, L. Caristina, S. Censuales, G. De Bellis, and C. Battaglia Algorithm for automatic genotype calling of single nucleotide polymorphisms using the full course of TaqMan real-time data. Nucleic Acids Res., January 1, 2006; 34(7): e56 - e56. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ranade, T. G. Kirchgessner, O. A. Iakoubova, J. J. Devlin, T. DelMonte, P. Vishnupad, L. Hui, Z. Tsuchihashi, F. M. Sacks, M. S. Sabatine, et al. Evaluation of the Paraoxonases as Candidate Genes for Stroke: Gln192Arg Polymorphism in the Paraoxonase 1 Gene Is Associated With Increased Risk of Stroke Stroke, November 1, 2005; 36(11): 2346 - 2350. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck Lys418Asn Polymorphism of the {alpha}2-Adrenoceptor Gene Relates to Serum Uric Acid Levels But Not to Insulin Sensitivity Hypertension, July 1, 2005; 46(1): 144 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Masuo, T. Katsuya, Y. Fu, H. Rakugi, T. Ogihara, and M. L. Tuck {beta}2- and {beta}3-Adrenergic Receptor Polymorphisms Are Related to the Onset of Weight Gain and Blood Pressure Elevation Over 5 Years Circulation, June 28, 2005; 111(25): 3429 - 3434. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sata, H. Yamada, K. Suzuki, Y. Saijo, E. H Kato, M. Morikawa, H. Minakami, and R. Kishi Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss Mol. Hum. Reprod., May 1, 2005; 11(5): 357 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nonaka, T. Naito, H. Chen, M. Yamamoto, K. Moro, H. Kiyono, H. Hamada, and H. Ishikawa Intestinal {gamma}{delta} T Cells Develop in Mice Lacking Thymus, All Lymph Nodes, Peyer's Patches, and Isolated Lymphoid Follicles J. Immunol., February 15, 2005; 174(4): 1906 - 1912. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu and G. C. Bazan Methods for strand-specific DNA detection with cationic conjugated polymers suitable for incorporation into DNA chips and microarrays PNAS, January 18, 2005; 102(3): 589 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Malhotra, G. M. Murphy Jr., and J. L. Kennedy Pharmacogenetics of Psychotropic Drug Response Am J Psychiatry, May 1, 2004; 161(5): 780 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marguerat, W. Y.S. Wang, J. A. Todd, and B. Conrad Association of Human Endogenous Retrovirus K-18 Polymorphisms With Type 1 Diabetes Diabetes, March 1, 2004; 53(3): 852 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Payne, D. J. Smyth, R. Pask, B. J. Barratt, J. D. Cooper, R. C.J. Twells, N. M. Walker, A. C. Lam, L. J. Smink, S. Nutland, et al. Haplotype Tag Single Nucleotide Polymorphism Analysis of the Human Orthologues of the Rat Type 1 Diabetes Genes Ian4 (Lyp/Iddm1) and Cblb Diabetes, February 1, 2004; 53(2): 505 - 509. [Abstract] [Full Text] |
||||
![]() |
S. MATSUNAGA, T. MARUYAMA, S. YAMADA, Y. MOTOHASHI, T. SHIGIHARA, A. SHIMADA, and T. SARUTA Nicotinamide Adenine Dinucleotide Phosphate Oxidase (NADPH Oxidase) P22 Phox C242T Gene Polymorphism in Type 1 Diabetes Ann. N.Y. Acad. Sci., November 1, 2003; 1005(1): 324 - 327. [Abstract] [Full Text] [PDF] |
||||